A comparison of the molecular bases for N-methyl-d-aspartate-receptor inhibition versus immobilizing activities of volatile aromatic anesthetics

Anesthesia and Analgesia

Volumn 108, Issue 1, 2009, Pages 168-175

  Sewell, Jason C ^a   Raines, Douglas E ^b,c   Eger, Edmond I ^d   Laster, Michael J ^d   Sear, John W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; AROMATIC HYDROCARBON; HALOGENATED HYDROCARBON; NR1 NMDA RECEPTOR; NR2B NMDA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ELECTRICITY; GEOMETRY; IMMOBILIZATION; MODEL; MOLECULAR DYNAMICS; MOLECULE; NONHUMAN; OOCYTE; PHARMACOPHORE; PRIORITY JOURNAL; QUANTUM MECHANICS; RAT; XENOPUS LAEVIS; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOTOR ACTIVITY; REPRODUCIBILITY; STRUCTURE ACTIVITY RELATION;

ANESTHETICS, INHALATION; ANIMALS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCARBONS, AROMATIC; HYDROCARBONS, HALOGENATED; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MOTOR ACTIVITY; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; REPRODUCIBILITY OF RESULTS; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 58749109967     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818de158     Document Type: Article

References (21)

1. Loftis JM, Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation and clinical implications. Pharmacol Ther 2003;97:55- 85
2. Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 2001;92:1182-91
3. Yamakura T, Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: comparison with isoflurane and ethanol. Anesthesiology 2000;93:1095-101
4. de Sousa SLM, Dickinson R, Lieb WR, Franks NP. Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 2000;92:1055-66
5. Solt K, Eger EI II, Raines DE. Differential modulation of human N-methyl-d-aspartate receptors by structurally diverse general anesthetics. Anesth Analg 2006;102:1407-11
6. Dutton RC, Laster MJ, Xing YL, Sonner JM, Raines DE, Solt K, Eger EI II. Do N-methyl-d-aspartate receptors mediate the capacity of inhaled anesthetics to suppress the temporal summation that contributes to minimum alveolar concentration? Anesth Analg 2006;102:1412-18
7. Eger EI II, Liao M, Laster MJ, Won A, Popovich J, Raines DE, Solt K, Dutton RC, Cobos FV, Sonner JM. Contrasting roles of the N-methyl-d- aspartate receptor in the production of immobilization by conventional and aromatic anesthetics. Anesth Analg 2006;102:1397-406
8. Kubinyi H. QSAR and 3D QSAR in drug design. I. Methodology. Drug Discov Today 1997;2:457-67
9. Sewell JC, Sear JW. Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anesthetics. Br J Anaesth 2004;92:45-53
10. Sewell JC, Sear JW. Derivation of preliminary threedimensional pharmacophores for nonhalogenated volatile anesthetics. Anesth Analg 2004;99:744 -51
11. Sewell JC, Sear JW. Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics. Anesth Analg 2006;102:764-71
12. Raines DE, Gioia F, Claycomb RJ, Stevens RJ. The N-methyl- daspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation- interactions. J Pharmacol Exp Ther 2004;311:14-21
13. Fang Z, Sonner J, Laster MJ, Ionescu P, Kandel L, Koblin DD, Eger EI II, Halsey MJ. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg 1996;83:1097-104
14. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ. Effects of the abused solvent toluene on recombinant Nmethyl- d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 1998; 286:334 - 40
15. Cramer RD III, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988;110:5959-67
16. Clark M, Cramer RD III, Jones DM, Patterson DE, Simeroth PE. Comparative molecular field analysis (CoMFA). Part 2. Toward its use with 3D-Structural databases. Tetrahedron Comput Methodol 1990;3:47-59
17. Kroemer RT, Hecht P. A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors. J Comput Aided Mol Des 1995;9:396-406
18. Dunn WJ III, Wold S, Edlund U, Hellberg S, Gasteiger J. Multivariate structure-activity relationships between data from a battery of biological tests and an ensemble of structure descriptors: the PLS method. Quant Struct Act Relat 1984;3:131-7
19. Cramer RD III, Bunce JD, Patterson DE, Frank IE. Crossvalidation, boot strapping and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct Act Relat 1988;7:18-25
20. Kelly EW, Solt K, Raines DE. Volatile aromatic anesthetics variably impact human g-Aminobutyric acid type A receptor function. Anesth Analg 2007;105:1287-92
21. Kroemer RT, Hecht P, Guessregen S, Liedl KR. Improving the predictive quality of CoMFA models. Perspect Drug Discov Design 1998;12:41-56